Accessibility Menu
 
PhenomeX logo

PhenomeX

(NASDAQ) BLI

Current PriceN/A
Market CapN/A
Since IPO (2020)-98%
5 YearN/A
1 Year-66%
1 Month+5%

PhenomeX Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$71.82M

Net Income (TTM)

$124.53M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PhenomeX

Industry

Life Sciences Tools and Services

Employees

285

CEO

Siddhartha C. Kadia, PhD

Headquarters

EmeryVille, CA 94608, US

BLI Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-56%

Return on Capital

-52%

Return on Assets

-43%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$53.78M

Operating Income

$94.54M

EBITDA

$92.49M

Operating Cash Flow

$47.54M

Capital Expenditure

$8.08M

Free Cash Flow

$55.62M

Cash & ST Invst.

$132.77M

Total Debt

$42.55M

PhenomeX Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$14.06M

-26.6%

Gross Profit

$6.04M

-53.2%

Gross Margin

42.97%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

285

N/A

Net Income

$50.24M

-95.1%

EBITDA

$47.21M

-112.4%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$7.01M

-93.3%

Accounts Receivable

$14.38M

-18.2%

Inventory

$41.45M

+164.7%

Long Term Debt

$23.95M

-45.5%

Short Term Debt

$0.00

-100.0%

Return on Assets

-43.36%

N/A

Return on Invested Capital

-52.35%

N/A

Free Cash Flow

$19.97M

-38.2%

Operating Cash Flow

$19.55M

-94.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMDXInsight Molecular Diagnostics Inc.
$3.44+4.88%
AADIAadi Bioscience, Inc.
$2.05-2.38%
IGMSIGM Biosciences, Inc.
$1.27+0.00%
JBIOJade Biosciences, Inc.
$16.02+14.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About BLI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.